Mason & Associates (California)’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$783K Buy
8,541
+48
+0.6% +$4.2K 0.13% 87
2026
Q1
$728K Buy
8,493
+143
+2% +$12.7K 0.14% 89
2025
Q4
$660K Buy
8,350
+76
+0.9% +$5.96K 0.12% 92
2025
Q3
$661K Buy
+8,274
New +$706K 0.13% 68
2022
Q2
Sell
-76,994
Closed -$5.84M 89
2022
Q1
$5.84M Hold
76,994
1.78% 18
2021
Q4
$6.57M Buy
+76,994
New +$6.01M 2% 19

Other funds holding CL

Mason & Associates (California)'s CL Position: Q2 2026 in Review

Mason & Associates (California) increased its Colgate-Palmolive (CL) stake by 0.57% in Q2 2026, buying an estimated $4.2K and bringing the position to 8,541 shares worth $783K. The position accounts for 0.13% of the portfolio, ranked #87.

Mason & Associates (California) first reported a position in CL in Q4 2021 and has held it in 6 quarters since. The position peaked at $6.57M in Q4 2021. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Mason & Associates (California) held 8,541 shares of Colgate-Palmolive worth $783K as of Q2 2026.
  • Mason & Associates (California) bought 48 Colgate-Palmolive shares in Q2 2026, an estimated $4.2K.
  • Colgate-Palmolive made up 0.13% of Mason & Associates (California)'s portfolio in Q2 2026, its #87 holding.
  • Mason & Associates (California) first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 6 quarters since.
  • Mason & Associates (California)'s Colgate-Palmolive position peaked at $6.57M in Q4 2021.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Mason & Associates (California)'s 13F filing for Q2 2026, filed 23 Jul 2026.